During the past decade, Medical College of Pennsylvania conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Medical College of Pennsylvania" are "Chronic Myeloproliferative Disorders" (1 trials), "Congestive Heart Failure" (1 trials), "Leukemia" (1 trials), "Myelodysplastic Syndromes" (1 trials) and "Thrombocytopenia" (1 trials). Many other conditions were trialed in "Medical College of Pennsylvania" in a lesser frequency.

Most popular intervention types in "Medical College of Pennsylvania" are "Drug" (2 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tolvaptan" (1 trials), "bone marrow ablation with stem cell support" (1 trials), "busulfan" (1 trials), "cytarabine" (1 trials) and "etoposide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical College of Pennsylvania" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Medical College of Pennsylvania". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Medical College of Pennsylvania, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical College of Pennsylvania, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".